Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema

BACKGROUND: Diabetic macular edema (DME) can be treated with different alternatives, among them Dexamethasone intravitreal implant 0.7 mg (DEX 0.7) has demonstrated that may improve both central macular thickness (CMT) and best corrected visual acuity (BCVA). This study aimed to evaluate the effect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Ophthalmol
Main Authors: Castro-Navarro, Verónica, Cervera-Taulet, Enrique, Navarro-Palop, Catalina, Monferrer-Adsuara, Clara, Hernández-Bel, Laura, Montero-Hernández, Javier
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6330395/
https://ncbi.nlm.nih.gov/pubmed/30634940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-018-1022-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados